Home›People›Brad Buscher
Brad Buscher

Brad Buscher

Executive Chairman at Triopsy Medical. Also CO-FOUNDER, EXECUTIVE CHAIRMAN, and CHIEF EXECUTIVE OFFICER at Intelligent Mapping.

ExecutiveDirectorRoles at 2 startups
Updated Nov 9, 2026·Latest SEC filing Aug 31, 2026·Suggest an edit

About Brad Buscher

Form D filings for Triopsy Medical from 2016 to 2024 list Brad Buscher as executive chairman.

Form D filings also name Brad Buscher as CO-FOUNDER, EXECUTIVE CHAIRMAN, and CHIEF EXECUTIVE OFFICER at Intelligent Mapping.

Brad Buscher first appears on SEC filings in 2016.

Experience

This experience comes from Brad Buscher's profile and from SEC filings. For roles taken from filings, the years are when the filings name Brad Buscher in the role, so the role may have started earlier or lasted longer.

Intelligent Mappings, LLC Current
Executive Chairman & CEO Intelligent Mapping LLC
2019 – Present
Triopsy Medical, Inc. Current
Executive Chairman Triopsy Medical Inc
2015 – Present · Aurora, CO
VaporLok Technology LLC Current
Chairman and CEO
2007 – Present
Banker's American Capital Corp Current
Chairman and CEO
1993 – Present
Intelligent Mapping, LLC
CO-FOUNDER, EXECUTIVE CHAIRMAN, and CHIEF EXECUTIVE OFFICER
2021 – 2026 · Park City, UT
Underground conduit mapping devices and software for data centers, telecom providers and transportation agencies.
Mercury Waste Solutions, LLC
Chairman and CEO
1996 – 2022
American Bancshares Inc
President and CEO
1979 – 1994

Key Colleagues at Startups

The people Brad Buscher works with at each company, as listed on that company's latest Form D.

Intelligent Mapping, LLC · Form D, Aug 31, 2026
Randy Whitaker
Randy Whitaker
Chief Financial Officer
James Sankovitz
James Sankovitz
Co-founder, Cso/cao and director
Eric Cope
Eric Cope
President
Triopsy Medical, Inc. · Form D, Feb 28, 2024
RL
DB
David Bostwick
Executive officer and director
JH
John Harper
Director
DW
MM

Sources

  1. SECIntelligent Mapping, LLC Form D, filed Aug 31, 2026
  2. SECTriopsy Medical, Inc. Form D, filed Feb 28, 2024